Examination of the action of 3,4-methylenedioxymethamphetamine on rat A10 dopamine neurons

Synapse

Volumn 23, Issue 1, 1996, Pages 52-57

  Gifford, Andrew N ^a   Minabe, Yoshio ^b   Toor, Alon ^a   Wang, Rex Y ^c   Ashby Jr , Charles R ^a  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

3,4 Methylenedioxymethamphetamine; 5 HT; A10; Dopamine; MDMA; Serotonin; Ventral tegmental area

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; BENSERAZIDE; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; FENCLONINE; HALOPERIDOL; LEVODOPA; METIROSINE; SEROTONIN; SEROTONIN ANTAGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOSE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NERVE CELL STIMULATION; NONHUMAN; PRIORITY JOURNAL; RACEMIC MIXTURE; RAT; SPIKE;

ANIMALS; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; TEGMENTUM MESENCEPHALI;

EID: 0029988307     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199605)23:1<52::AID-SYN6>3.0.CO;2-G     Document Type: Article

References (39)

1. Andén, N.E., and Grabowska, M. (1976) Pharmacological evidence for a stimulation of dopamine neurons by noradrenaline neurons in the brain. Eur. J. Pharmacol., 39:275-282.
2. Bonish, H., and Trendelenburg, U. (1988) The mechanism of action of indirectly acting sympathomimetic amines. In: Handb. Exp. Pharm. 90/1, catecholamines. U. Trendelenburg and N. Weiner, eds. Springer-Verlag, Berlin, pp. 247-277.
3. Bunney, B.S., Walters, J.R., Roth, R.H., and Aghajanian, G.K. (1973) Dopaminergic neurons: Effect of antipsychotic drugs and amphetamine on single cell activity. J. Pharmacol. Exp. Ther., 185:560-571.
4. Callahan, P.M., and Appel, J.B. (1988) Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline. J. Pharmacol. Exp. Ther., 246:866-870.
5. Callaway, C.W., Johnson, M.P., Gold, L.H., Nichols, D.E., and Geyer, M.A. (1991) Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists. Psychopharmacology, 104:293-301.
6. Einhorn, L.C., Johansen, P.A., and White, F.J. (1988) Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: Studies in the ventral tegmental area. J. Neurosci., 8:100-112.
7. French, E.D., and Ceci, A. (1990) Non-competitive N-methyl-D-aspartate antagonists are potent activators of ventral tegmental A10 dopamine neurons. Neurosci. Lett., 119:159-162.
8. 14C]p-chlorophenylalanine as an inhibitor of tryptophan 5-hydroxylase. J. Neurochem., 17:1221-1235.
9. 3 antagonists. Pharmacol. Biochem. Behav., 43:1099-1106.
10. Glennon, R.A., Yousif, M., and Patrick, G. (1988) Stimulus properties of 1-(3,4-Methylenedioxyphenyl)-2-aminopropane (MDA) analogs. Pharmacol. Biochem. Behav., 29:443-449.
11. Grace, A.A., and Bunney, B.S. (1984) The control of firing pattern in nigral dopamine neurons: Burst firing. J. Neurosci., 4:2877-2890.
12. Grenhoff, H., and Svensson, T.H. (1989) Clonidine modulates dopamine cell firing in rat ventral tegmental area. Eur. J. Pharmacol., 165:11-18.
13. Guan, X.-M., and McBride, W.J. (1989) Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release. Brain Res Bull., 23:541-547.
14. Gysling, K., and Wang, R.Y. (1983) Morphone-induced activation of AlO dopamine neurons in the rat. Brain Res., 277:119-127.
15. Hekmatpanah, C.R., and Peroutka, S.J. (1990) 5-Hydroxytryptamine uptake blockers attenuate the 5-hydroxytyptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents. Eur. J Pharmacol., 177:95-98.
16. Hervé, D., Blanc, G., Glowinski, J., and Tassin, J.P. (1982) Reduction of dopamine utilization in the prefrontal cortex but not in the nucleus accumbens after selective destruction of noradrenergic fibers innervating the ventral tegmental area in the rat. Brain Res., 237:510-516.
17. Hiramatsu, M., and Cho, A.K. (1990) Enantiomeric differences in the effects of 3,4-methylenedioxymethamphetamine on extracellular monamines and metabolites in the striatum of freely-moving rats: An in vivo microdialysis study. Neuropharmacology, 29:269-275.
18. 3H]dopamine release from superfused rat brain slices. Eur. J. Pharmacol., 132:269-276.
19. 3H]Monamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetamine and p-choloroamphetamine analogues. Eur. J. Pharmacol., 200:9-16.
20. Kelland, M.D., Freeman, A.S., and Chiodo, L.A. (1989) (±)-3,4-methylenedioxymethamphetamine-induced changes in the basal activity and pharmacological responsiveness of nigrostriatal dopamine neurons. Eur. J. Pharmacol., 169:11-21.
21. Kelland, M.D., Freeman, A.S., Rubin, J., and Chiodo, L.A. (1993) Ascending afferent regulation of rat midbrain dopamine neurons. Brain Res. Bull., 31:539-546.
22. McKenna, D.J., and Peroutka, S.J. (1990) Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy"). J. Neurochem., 54:14-22.
23. McMillen, B.A. (1983) CNS stimulants: Two distinct mechanisms of action for amphetamine-like drugs. TIPS, 4:429-432.
24. Mereu, G., Kong-Woo, P.Y., Boi, V., Gessa, G.L., Naes, L., and Thomas, C.W. (1987) Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine. Eur. J. Pharmacol., 141:359-399.
25. Moore, K.E., and Rech, R.H. (1967) Reversal of α-methyltyrosine-induced behavioural depression with dihydroxyphenylalanine and amphetamine. J. Pharm. Pharmacol., 19:405-407.
26. Oberlender, R., and Nichols, D.E. (1988) Drug discrimination studies with MDMA and amphetamine. Psychopharmacology, 95:71-76.
27. 3H]-5-hydroxytryptamine. Neuroscience, 6:115-138.
28. Parker, E.M., and Cubeddu, L.X. (1986) Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. II. Release in the presence of vesicular transmitter stores. J. Pharmacol. Exp. Ther., 237:193-203.
29. Paxinos, G., and Watson, C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd ed. Academic Press, New York.
30. Pessia, M., Jian, Z-G., North, R.A., and Johnson, S.W. (1994) Actions of 5-hydroxytryptamine on ventral tegmental area neurons of the rat in vitro. Brain Res., 654:324-330.
31. Phillipson, O.T. (1979) Afferent projections to the ventral tegmental area of Tsai and interfascicular nucleus: A horseradish peroxidase study in the rat. J. Comp. Neurol. 187:117-144.
32. Pitts, D.K., and Marwah, J. (1988) Cocaine and central monaminergic neurotransmission: A review of electrophysiological studies and comparison to amphetamine and antidepressants. Life Sci., 42:949-968.
33. Schechter, M.D. (1989) Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"), Pharmacol. Biochem. Behav., 31:817-824.
34. Scheel-Krüger, J. (1971) Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines in the brain. Eur. J. Pharmacol., 14:47-59.
35. 3H]leucine and horseradish peroxidase. Brain Res., 178:17-40.
36. 3H]monoamines into synaptosomes from different regions of rat brain. Biochem. Pharmacol., 36:2297-2303.
37. Steigrad, P., Tobler, I., Waser, P.G., and Borbély, A.A. (1978) Effect of p-cholorphenylalanine on cerebral serotonin binding, serotonin concentration and motor activity in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol., 305:143-148.
38. Wang, R.Y. (1981a) Dopaminergic neurons in the rat ventral tegmental area. I, Identification and characterization. Brain Res. Rev, 3:123-140.
39. Wang, R.Y. (1981b) Dopaminergic neurons in the rat ventral tegmental area. III. Effects of d- and l-amphetamine. Brain Res. Rev., 3:153-165.